Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,317 papers from all fields of science
Search
Sign In
Create Free Account
BCLC Stage A Hepatocellular Carcinoma
Known as:
Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma
Early hepatocellular carcinoma. Patients are candidates for radical therapies (resection, liver transplantation, or percutaneous treatments). (HPB…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
24 relations
Abdominal Pain
Aberrant DNA Methylation
BCLC Stage
Bile Ducts, Extrahepatic
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Application of BCLC-B subclassification and Hong Kong Liver Cancer Systems to intermediate stage hepatocellular carcinoma
G. Ricco
,
C. Demirtas
,
+4 authors
M. Brunetto
2020
Corpus ID: 213579629
2019
2019
Evaluating the Ability of the New Subclassification to Prognosticate Outcomes Following Hepatectomy for Patients with HBV-Related HCC
Yunhong Tian
,
H. Lyu
,
Yunhong He
,
Hari Krishna Kanduri
Journal of Gastrointestinal Cancer
2019
Corpus ID: 3741387
BackgroundRecently, experts proposed subclassification for BCLC B patients. In this study, we aimed to evaluate the efficient of…
Expand
2018
2018
Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection
Chuan Li
,
Xiaoyun Zhang
,
+7 authors
Liping Chen
Medicine
2018
Corpus ID: 51697379
Abstract There is little information regarding the predictive ability of albumin-bilirubin grades (ALBI) plus platelet-to…
Expand
Review
2017
Review
2017
Changes of platelet times neutrophil to lymphocyte ratio predict BCLC stage A hepatocellular carcinoma survival
C. Jin
,
Chuan Li
,
+6 authors
Mingqing Xu
Medicine
2017
Corpus ID: 5716034
Abstract Platelet, neutrophil, and lymphocyte ratio (PNLR) has its own unique role in influencing postoperative recurrence for…
Expand
2016
2016
Development of the new prognostic staging system and proposal of treatment plans based on the multivariate survival analyses (MVA) after doxorubicin drug eluting beads trans-arterial…
H. Prajapati
,
Hyun S Kim
2016
Corpus ID: 76377864
2016
2016
Comparison of Treatment Outcome between Living Donor Liver Transplantation and Sorafenib for Patients with BCLC B or C Stage Hepatocellular Carcinoma
Y. Cho
,
J-H Lee
,
+7 authors
J. Yoon
2016
Corpus ID: 78858566
2016
2016
Prognostic Validation of Proposed BCLC-B Substaging System in Hepatocellular Carcinoma Patients Treated by Transarterial Chemoembolization
M. Biolato
,
G. Gallusi
,
+11 authors
A. Grieco
2016
Corpus ID: 78634221
2015
2015
Improvement of survival in patients with intermediate stage (BCLC-B) hepatocellular acrcinoma complicating liver cirrhosis by combination therapy with radiofrequency ablation and transcatheter…
P. Ventura
,
M. Santis
,
+7 authors
A. Pietrangelo
2015
Corpus ID: 81374557
2014
2014
Su1468 Downstaging Therapy in Patients With Intermediate Stage HCC (BCLC B) as Bridge for Transplantation: The Hepatocatt Experience
T. Rienzo
,
V. Cesario
,
+14 authors
A. Gasbarrini
2014
Corpus ID: 71709872
2014
2014
P.17.4 DOWNSTAGING THERAPY IN PATIENTS WITH INTERMEDIATE STAGE HCC (BCLC B) AS BRIDGE FOR TRANSPLANTATION: THE HEPATOCATT EXPERIENCE
T. Rienzo
,
V. Cesario
,
+15 authors
S. G. Hepatocatt
2014
Corpus ID: 75252617
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE